Persistence with oral bisphosphonates and denosumab among older adults in primary care in Ireland

SUMMARY: Gaps in pharmacological treatment for osteoporosis can reduce effectiveness. Among older adults, we found about half of new users of oral bisphosphonate and denosumab persisted with their treatment at 2 years, with few switching to alternative therapy. Persistence is suboptimal and warrants...

Descripción completa

Detalles Bibliográficos
Autores principales: Walsh, Mary E., Fahey, Tom, Moriarty, Frank
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer London 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053179/
https://www.ncbi.nlm.nih.gov/pubmed/33864529
http://dx.doi.org/10.1007/s11657-021-00932-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053179/
https://www.ncbi.nlm.nih.gov/pubmed/33864529
http://dx.doi.org/10.1007/s11657-021-00932-7

Ejemplares similares